Please login to the form below

Not currently logged in

Havas Lynx creates new med ed and scientific exchange agency

Will be known as Havas Lynx Medical

Havas Lynx MedicalHavas Lynx, the global healthcare communications group, has announced that it is creating a new medical education and scientific exchange agency called Havas Lynx Medical.

The new agency will provide education to health professionals and facilitate the exchange of scientific information between the clinical and pharmaceutical communities. Havas Lynx Medical will exploit both traditional and new methodologies, drawing on the digital capabilities within the parent group Havas Lynx.

Dr Nick Broughton has been appointed medical director and will lead the development of Havas Lynx Medical.

Dr Broughton has 17 years' pharmaceutical industry experience within clinical research, medical affairs and regulatory affairs, including director roles in the UK and Europe. In addition to his work at Havas Lynx Medical he is also a director of, a specialist consultancy providing advice and education in pharmaceutical business ethics and compliance.

“Good medical education and scientific exchange creatively delivered has the chance to make those little differences to clinical practice that can improve the life of individual patients,” said Dr Broughton. “It's that fact and the opportunity to innovate to make it happen that meant this role was something that was too good to miss.”

David Hunt was appointed CEO of Havas Lynx in June 2013 having been with the agency for 15 years. Commenting on the set-up of the new agency Hunt said: “We recognised very early on that medical education is a very competitive arena and that if we couldn't offer something new we shouldn't enter it. Nick's clinical perspective coupled with his industry experience, our digital pedigree and the enthusiasm of the team we have recruited convince us that Havas Lynx Medical will deliver a step change in medical education.”

23rd July 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...